Alto Neuroscience, Inc. (ANRO)
24.91
-0.75
(-2.92%)
USD |
NYSE |
May 01, 16:00
24.91
0.00 (0.00%)
After-Hours: 20:00
Alto Neuroscience Total Assets (Quarterly) : 184.69M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | -- |
| Immunovant, Inc. | 1.052B |
| Halozyme Therapeutics, Inc. | 2.714B |
| Vertex Pharmaceuticals, Inc. | 26.14B |
| Fortress Biotech, Inc. | 185.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 33.55M |
| Shareholders Equity (Quarterly) | 151.14M |
| Debt to Equity Ratio | 0.1585 |
| Current Ratio | 15.69 |
| Net Debt Paydown Yield | -0.25% |